Results 171 to 180 of about 139,558 (270)

Weight changes among antiretroviral therapy-naïve people living with human immunodeficiency virus in Lagos, Nigeria. [PDF]

Front Public Health
Odubela OO, Peer N, Odunukwe NN, Musa AZ, Salako BL, Kengne AP.   +5 more
europepmc   +1 more source

Assessment of Antiretroviral Therapy by Plasma Viral Load Testing

, 1995
John C. Kappes, Michael S. Saag, George M. Shaw, Beatrice H. Hahn, Paul Chopra, Shande Chen, Emilio A. Emini, Randi McFarland, Limei Yang, Michael Piatak, Jeffrey D. Lifson   +10 more
openalex   +1 more source

Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III studies

HIV Medicine, Volume 26, Issue 6, Page 858-869, June 2025.
Abstract Introduction Black and Hispanic/Latine people are disproportionately affected by HIV‐1 and may have a greater risk of comorbidities than non‐Black and non‐Hispanic/Latine people with HIV. However, they have historically been underrepresented in HIV clinical studies.
C. Martorell, M. Ramgopal, D. Hagins, O. Osiyemi, J. R. Arribas, M. Berhe, Y. Yazdanpanah, C. Orkin, L. Santiago, C. Rosero, N. Unger, H. Liu, R. Rogers, J. T. Hindman, A. Wurapa   +14 more
wiley   +1 more source

Prevalence of thyroid dysfunction in highly active antiretroviral therapy -Exposed people living with human immunodeficiency virus. [PDF]

Thyroid Res
Adan AA, Ojuang RA, Nyanjom SG, Maina EK.   +3 more
europepmc   +1 more source

Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use

HIV Medicine, Volume 26, Issue 6, Page 870-878, June 2025.
Abstract Introduction Integrase strand transfer inhibitors (INSTIs) are the mainstay of treatment in adults and children living with HIV. Weight gain has been associated with INSTI use in adults; however, less data exist on its effects on younger patients.
Kathleen J. Pincus, Nabila Faridi, Patrick Amadeus Ryscavage, Hyunuk Seung, Kristine A. Parbuoni, Matthew Grant, Neha Sheth Pandit   +6 more
wiley   +1 more source

Antiretroviral therapy in people with HIV and end-stage kidney disease. [PDF]

AIDS
Spencer M, Pieri C, Hamzah L, Popoola J, Shah S, Jones R, Levy J, Murphy M, Booth J, Post FA.   +9 more
europepmc   +1 more source

Activated Memory CD4 ⁺ T Helper Cells Repopulate the Intestine Early following Antiretroviral Therapy of Simian Immunodeficiency Virus-Infected Rhesus Macaques but Exhibit a Decreased Potential To Produce Interleukin-2

, 1999
Joseph J. Mattapallil, Zeljka Smit‐McBride, Peter J. Dailey, Satya Dandekar   +3 more
openalex   +1 more source

Antiretroviral combination therapy and HIV infection [PDF]

, 1998
J. McMenamin, G. Allardice, D. Goldberg, T. Parpira, G. Raab, R. Thiebaut, Frantz Thiessard, L. D. Merchadou, C. Marimoutou, F. Dabis   +9 more
openalex   +1 more source

Rethinking HIV treatment: How non‐integrase strand regimens may hold the key to better immune health

HIV Medicine, Volume 26, Issue 6, Page 879-887, June 2025.
Abstract Purpose HIV outcome changed drastically with antiretroviral (ARV) therapy, especially after the introduction of second‐generation integrase strand transfer inhibitors (INSTIs). Despite these advances, however, chronic immune activation and exhaustion, marked by programmed cell death 1 (PD‐1) and programmed death ligand 1 (PD‐L1) upregulation ...
Bogusz Aksak‐Wąs, Karolina Skonieczna‐Żydecka, Miłosz Parczewski, Rafał Hrynkiewicz, Filip Lewandowski, Karol Serwin, Kaja Mielczak, Franciszek Lenkiewicz, Paulina Niedźwiedzka‐Rystwej   +8 more
wiley   +1 more source

Association between antiretroviral therapy and dental caries in children and adolescents with HIV: a systematic review and meta-analysis. [PDF]

BMC Oral Health
Aguirre-Ipenza R, Bautista-Pariona A, Viguria-Chavez Y, Huapaya-Cabrera AH, Coronel-Zubiate FT, Luján-Valencia SA, Amaya-Riveros E, Arbildo-Vega HI.   +7 more
europepmc   +1 more source